SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001104659-22-060477
Filing Date
2022-05-13
Accepted
2022-05-13 17:17:25
Documents
1
Period of Report
2022-03-31
Effectiveness Date
2022-05-13

Document Format Files

Seq Description Document Type Size
1 NT 10-Q tm2215560d2_nt10q.htm NT 10-Q 24778
  Complete submission text file 0001104659-22-060477.txt   25908
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-39788 | Film No.: 22924036
SIC: 2834 Pharmaceutical Preparations